Also interesting
Xpress Biologics moves up a gear with Polyplus & SSB
Belgian CDMO Xpress Biologics becomes a strategic enabler of gene therapy production for Polyplus (now to be acquired by Sartorius Stedim Biotech).
Training in Life Sciences: Belgium, the place to be
Belgium is strengthening its strategy to become a European training powerhouse for the Life Sciences industry.
Eurogentec: €14Mio invested to increase mRNA production fivefold
Japanese company Kaneka invests €14Mio in Belgian subsidiary Eurogentec, increasing mRNA fivefold to meet gene therapy companies' production needs.